Ali Health (00241) reported an adjusted net profit of 2.3262 billion yuan for the fiscal year, representing a year-on-year increase of 19.3%.
Ali Health (00241) announced its annual results for the fiscal year ended March 31, 2026. Total revenue amounted to approximately RMB 34.255 billion, representing a year-on-year increase of 12.0%. Net profit reached approximately RMB 1.9363 billion, marking a year-on-year growth of 35.2%. Adjusted net profit was RMB 2.3262 billion, up by 19.3% year-on-year, with the adjusted net profit margin improving from 6.4% to 6.8%. A final dividend of 5.95 cents per share and a special dividend of 13.52 cents per ordinary share are proposed.
Selected Hong Kong Stock Announcements | SMIC's Q1 revenue exceeds $2.5 billion; Ali Health's profit for the last fiscal year increased by over 30% year-on-year.
① SMIC's revenue in the first quarter exceeded 2.5 billion US dollars. What was the year-on-year growth rate? ② Ali Health's profit in the previous fiscal year increased by more than 30% year-on-year. What was the scale?
Ali Health (00241.HK) proposes to reduce the share premium by 10 billion for dividend distribution.
Ali Health (00241.HK) has declared a final dividend totaling RMB 0.1947, comprising a final dividend of RMB 0.0595 and a special dividend of RMB 0.1352. As of March 31, 2026, the company does not have sufficient distributable profits to shareholders. Therefore, it plans to fund the distribution by reducing part of the amount credited to the share premium account and transferring such amounts to the distributable profits account for payment as final and special dividends. As of March 31, 2026, the amount credited to the share premium account is approximately RMB 51.687 billion, while the company’s accumulated deficit stands at around RMB 1.178 billion.
Ali Health (00241): Sheng Mengyue has been appointed as Executive Director and Chief Financial Officer.
Ali Health (00241) announced that, effective at the close of business on May 15, 2026: (i) Ms. Sheng Mengyue has been appointed as an executive director and chief financial officer; and (ii) Mr. Tu Yanwu has tendered his resignation as an executive director and chief financial officer.
Ali Health (00241) will distribute a special dividend of RMB 0.1352 per share on September 2.
Ali Health (00241) announced that the company will distribute a special dividend of RMB 0.1352 per share on September 2, 2026, for the fiscal year ended March 31, 2026.
Ali Health (00241) will distribute a final dividend of RMB 0.0595 per share on September 2.
Ali Health (00241) announced that it will distribute a final dividend of RMB 0.0595 per share for the fiscal year ended March 31, 2026, on September 2, 2026.